🔗 Share this article

An underground market for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.

Investigational Drug Acquiring Popularity Online

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Viewers are encouraged to message these profiles directly for source information, while also receiving discount codes.

Active Commerce on Social Networks

Additionally, a robust market exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and claims of next-day British shipping. Vendors promote the drug there before directing buyers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Voice Worries

However, physicians and pharmacists have warned that the sale of what is still an unapproved drug in the UK is a cause for concern and could result in individuals administering substances of unknown origin.

Several professionals stated the popularity for the experimental drug could be connected to the rising cost of approved slimming treatments such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate medicines, marketing, and customer regulations, potentially leading to fines, prosecution or prison.

Service Reaction and Content Elimination

According to the social media company, the platform has removed problematic content and banned associated hashtags and query recommendations. The organization said it was dedicated to maintaining the platform secure and allocating resources in strengthening enforcement strategies.

Online Marketplace Activities

Research also discovered groups with up to nine thousand members selling the experimental drug using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of members, filled with images of weight loss, positive reviews and step-by-step instructions for mixing or administering at home.

Within moments of joining one group, a vendor posted contact information, where the majority of purchases occur. The seller sent an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about weight, medical conditions or previous experience.

Item Information and Pricing

Within these communities, messages display dark colored parcels with postal service stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with purified liquid, or pre-filled injectors typically sold at £160 for 20mg. When asked how much time a injector should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A representative for Telegram stated it regularly moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering substances they cannot confirm. Although the science behind retatrutide is valid, these online versions may not include what they claim,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the surge in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are using social media. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.

Her staff has already encountered patients harmed by self-injection from unverified sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may expose users to potentially significant health risks”.